We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
We are deeply worried about the current situation in Ukraine. The absolute priority of OCT Clinical right now is the safety and wellbeing of our staff members.
We remain in permanent contact with all our employees in Ukraine and are doing everything we can to prioritize their safety, adapting our plans in line with constantly changing circumstances.
We want nothing more than everybody to live in peace and safety, and hope for this nightmare to end as soon as possible.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
